NEWLINK GENETICS CORP's ticker is NLNK and the CUSIP is 651511107.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $2,415,000 | -34.3% | 507,273 | 0.0% | 0.02% | -41.9% |
Q1 2018 | $3,678,000 | -55.0% | 507,273 | -49.6% | 0.03% | -56.3% |
Q4 2017 | $8,169,000 | -20.3% | 1,007,273 | 0.0% | 0.07% | -14.5% |
Q3 2017 | $10,254,000 | +179.0% | 1,007,273 | +101.5% | 0.08% | +159.4% |
Q2 2017 | $3,675,000 | – | 500,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 1,840,294 | $34,561,000 | 3.61% |
RA Capital Management | 500,000 | $9,390,000 | 0.98% |
Knoll Capital Management, LLC | 77,437 | $1,454,000 | 0.78% |
WALL STREET ASSOCIATES | 349,800 | $6,569,000 | 0.61% |
Montibus Capital Management LLC | 251,811 | $4,729,011,000 | 0.51% |
PointState Capital LP | 1,000,000 | $18,780,000 | 0.32% |
Prospera Financial Services Inc | 40,826 | $838,000 | 0.32% |
TIVERTON ASSET MANAGEMENT LLC | 500,000 | $9,390,000 | 0.23% |
BAILARD, INC. | 46,000 | $864,000 | 0.16% |
BANKERS TRUST CO | 12,277 | $231,000 | 0.16% |